Radiomics approaches to predict PD-L1 and PFS in advanced non-small cell lung patients treated with immunotherapy: a multi-institutional study

With the increasing use of immune checkpoint inhibitors (ICIs), there is an urgent need to identify biomarkers to stratify responders and non-responders using programmed death-ligand (PD-L1) expression, and to predict patient-specific outcomes such as progression free survival (PFS). The current stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yolchuyeva, Sevinj, Giacomazzi, Elena, Tonneau, Marion, Lamaze, Fabien, Orain, Michele, Coulombe, François, Malo, Julie, Belkaid, Wiam, Routy, Bertrand, Joubert, Philippe, Manem, Venkata S. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329671/
https://www.ncbi.nlm.nih.gov/pubmed/37422576
http://dx.doi.org/10.1038/s41598-023-38076-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329671/
https://www.ncbi.nlm.nih.gov/pubmed/37422576
http://dx.doi.org/10.1038/s41598-023-38076-y

Ejemplares similares